Reference Intervals for N-Terminal Pro-B-Type Natriuretic Peptide in Amniotic Fluid between 10 and 34 Weeks of Gestation

Background In adult and pediatric cardiology, n-terminal pro-B-type natriuretic peptide (nt-proBNP) serves as biomarker in the diagnosis and management of cardiovascular dysfunction. Elevated levels of circulating nt-proBNP are present in fetal conditions associated with myocardial pressure or volume load. Compared to fetal blood sampling, amniocentesis is technically easier and can be performed from early pregnancy onwards. We aimed to investigate amniotic fluid (AF) nt-proBNP concentrations in normal pregnancies between 10 and 34 weeks of gestation. Methods Nt-proBNP and total protein (TP) was measured in AF by chemiluminescence assay (photometry, respectively). To adjust for a potential dilutional effect, the AF-nt-proBNP/AF-TP ratio was analyzed. Reference intervals were constructed by regression modeling across gestational age. Results 132 samples were analyzed. A negative correlation between AF-nt-proBNP/AF-TP ratio and gestational age was observed. Curves for the mean and the 5% and 95% reference interval between 10 and 34 weeks of gestation were established. Conclusion In normal pregnancy, nt-proBNP is present in AF and decreases during gestation. Our data provide the basis for research on AF-nt-proBNP as biomarker in fetal medicine.

[1]  Pedro Lozano.  Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.

[2]  U. Gembruch,et al.  Old tool – new application: NT‐proBNP in fetal medicine , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  C. O'connor,et al.  Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis , 2014, European heart journal.

[4]  S. Louey,et al.  Regulation of intramembranous absorption and amniotic fluid volume by constituents in fetal sheep urine. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  R. Fimmers,et al.  Cardiorenal Syndrome is Present in Human Fetuses with Severe, Isolated Urinary Tract Malformations , 2013, PloS one.

[6]  T. Yamada,et al.  B-type natriuretic peptide levels are correlated with birth-weight discordance in monochorionic-diamniotic twins without twin–twin transfusion syndrome , 2013, Journal of Perinatology.

[7]  J. Januzzi,et al.  Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. , 2013, Circulation.

[8]  Akshay S. Desai,et al.  Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Not Useful in Heart Failure Management The Art of Medicine Remains Long , 2013, Circulation.

[9]  Juerg Schwitter,et al.  Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104 , 2013 .

[10]  J. Deprest,et al.  Minimally invasive fetal therapy. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[11]  R. Fimmers,et al.  Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment , 2012, Pediatric Research.

[12]  D. Valsky,et al.  Functional assessment of the fetal heart: a review , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  B. Stoffel‐Wagner,et al.  N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations , 2012, Clinical Research in Cardiology.

[14]  E. Mayatepek,et al.  Urinary NT-proBNP, NGAL, and H-FABP May Predict Hemodynamic Relevance of Patent Ductus Arteriosus in Very Low Birth Weight Infants , 2012, Neonatology.

[15]  F. Krummenauer,et al.  Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities , 2011, Journal of perinatal medicine.

[16]  B. Tutschek,et al.  Techniques for assessing cardiac output and fetal cardiac function. , 2011, Seminars in fetal & neonatal medicine.

[17]  Eduard Gratacos,et al.  The making of fetal surgery , 2010, Prenatal diagnosis.

[18]  G. Marceau,et al.  Intra‐amniotic N‐terminal pro‐brain natriuretic peptide in severe twin‐to‐twin transfusion syndrome treated by fetoscopic laser coagulation , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[20]  J. Lock,et al.  Current status of fetal cardiac intervention. , 2010, Circulation.

[21]  B. Stoffel‐Wagner,et al.  Reference values for N-terminal pro-B-type natriuretic peptide in fetal circulation between 20 and 34 weeks of gestation. , 2010, Clinical biochemistry.

[22]  T. Crombleholme,et al.  The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome. , 2009, American journal of obstetrics and gynecology.

[23]  W. Arzt,et al.  Amino Terminal pro B-Type Natriuretic Peptide Levels Are Elevated in the Cord Blood of Neonates With Congenital Heart Defect , 2009, Pediatric Research.

[24]  S. Gudmundsson,et al.  Biochemical tissue-specific injury markers of the heart and brain in postpartum cord blood. , 2009, American journal of obstetrics and gynecology.

[25]  M. Cuello,et al.  Brain Natriuretic Peptide (BNP) Produced by the Human Chorioamnion May Mediate Pregnancy Myometrial Quiescence , 2009, Reproductive Sciences.

[26]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[27]  Y. Pinto,et al.  The diagnostic value of serum and urinary NT-proBNP for heart failure , 2008, Annals of clinical biochemistry.

[28]  O. Vuolteenaho,et al.  Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[29]  D. Morrow,et al.  Benchmarks for the Assessment of Novel Cardiovascular Biomarkers , 2007, Circulation.

[30]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[31]  J. Mair,et al.  N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. , 2005, Clinical chemistry.

[32]  A. Nir,et al.  N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. , 2005, Clinical chemistry.

[33]  R. Brace,et al.  Regulation of amniotic fluid volume: intramembranous solute and volume fluxes in late gestation fetal sheep. , 2004, American journal of obstetrics and gynecology.

[34]  L. Ng,et al.  Diagnosis of heart failure using urinary natriuretic peptides. , 2004, Clinical science.

[35]  M. Ross,et al.  National Institute of Child Health and Development Conference summary: Amniotic fluid biology - basic and clinical aspects , 2001, The Journal of maternal-fetal medicine.

[36]  S. Blackwell,et al.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. , 2000, The New England journal of medicine.

[37]  R. Brace,et al.  Effect of esophageal ligation on amniotic fluid volume and urinary flow rate in fetal sheep. , 2000, American journal of obstetrics and gynecology.

[38]  Giancarlo Mari,et al.  NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION , 2000 .

[39]  P. Royston,et al.  How to construct ‘normal ranges’ for fetal variables , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[40]  H. Itoh,et al.  Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. , 1993, The Journal of clinical endocrinology and metabolism.

[41]  W. Schmidt.  The amniotic fluid compartment: the fetal habitat. , 1992, Advances in anatomy, embryology, and cell biology.

[42]  I. Szymusik,et al.  N-terminal pro-B-type natriuretic peptide: a potential marker of fetal heart failure in hemolytic disease. , 2011, Neuro endocrinology letters.

[43]  J. Deprest,et al.  Amniotic fluid markers of fetal cardiac dysfunction in twin-to-twin transfusion syndrome. , 2010, American journal of obstetrics and gynecology.

[44]  M. Emdin,et al.  Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. , 2004, Clinical chemistry.

[45]  R. Brace.  Progress toward understanding the regulation of amniotic fluid volume: water and solute fluxes in and through the fetal membranes. , 1995, Placenta.